1. To study the rates of ADR reporting and the structure in the Astrakhan region at the regional center for drug safety monitoring. 2. To analyze the outcomes of registered adverse drug reactions. 3. To determine the causality of adverse drug reactions. 4. To identify reports on the ineffectiveness of drugs. 5. To analyze the rates and structure of ADR reporting for drugs prescribed off-label.
METHODS:
We studied spontaneous adverse event reporting. The adverse event reports received by the regional CDSM for the period of 2010 to 2014 was analyzed. The groups of drugs were categorized according by Anatomical Therapeutic Chemical classifi cation system. The data were analyzed using Microsoft Offi ce Excel. The likelihood of whether an ADR was actually due to the drugs was assessed with the Naranjo algorithm.
RESULTS:
The analysis of the results showed that the establishment of the CDSM in September 2010, contributed to improvement of drug safety monitoring in health facilities of the region. Noteworthy was the increasing the number of adverse event reports in 2011 and 2012, compared with the beginning of the year 2010, when the CDSM was not yet functioning.
The decrease of adverse event reporting in 2013 and 2014 was due to the fact that doctors in the region had access to better ADR drug information. Along with the increasing number of adverse event reporting we also noted the increase in the number of health facilities that monitored drug safety. The number of health facilities that reported, doubled from 2010 to 2014. We observed the increase in the number of adverse event reports submitted by pharmaceutical companies. General anti-infective drugs for systemic use (class J) were the most common cause of all registered ADRs (44%). Drugs
